Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

被引：10

作者：

Chisholm, Julia ^{[1
,2
]}

Mandeville, Henry ^{[1
,2
]}

Adams, Madeleine ^{[3
]}

Minard-Collin, Veronique ^{[4
]}

Rogers, Timothy ^{[5
]}

Kelsey, Anna ^{[6
]}

Shipley, Janet ^{[7
]}

van Rijn, Rick R. ^{[8
]}

de Vries, Isabelle ^{[9
]}

van Ewijk, Roelof ^{[9
]}

de Keizer, Bart ^{[9
]}

Gatz, Susanne A. ^{[10
,11
]}

Casanova, Michela ^{[12
]}

Hjalgrim, Lisa Lyngsie ^{[13
]}

Firth, Charlotte ^{[11
]}

Wheatley, Keith ^{[11
]}

Kearns, Pamela ^{[11
]}

Liu, Wenyu ^{[11
]}

Kirkham, Amanda ^{[11
]}

Rees, Helen ^{[14
]}

Bisogno, Gianni ^{[15
]}

Wasti, Ajla ^{[7
]}

Wakeling, Sara ^{[16
]}

Heenen, Delphine ^{[17
]}

Tweddle, Deborah A. ^{[18
]}

Merks, Johannes H. M. ^{[9
]}

Jenney, Meriel ^{[3
]}

机构：

[1] Royal Marsden Hosp, Children & Young Peoples Unit, Sutton SM2 5PT, England

[2] Inst Canc Res, Sutton SM2 5PT, England

[3] Childrens Hosp Wales, Dept Paediat Surg, Cardiff CF14 4XW, Wales

[4] Gustave Roussy, Dept Paediat Oncol, F-75015 Paris, France

[5] Univ Hosp Bristol & Weston NHS Fdn Trust, Dept Paediat Surg, Bristol BS1 3NU, England

[6] Manchester Univ NHS Fdn Trust, Royal Manchester Childrens Hosp, Dept Paediat Histopathol, Manchester M13 9WL, England

[7] Inst Canc Res, London SW7 3RP, England

[8] Univ Amsterdam, Dept Radiol & Nucl Med, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands

[9] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands

[10] Birmingham Womens & Childrens NHS Fdn Trust, Birmingham B15 2TG, England

[11] Univ Birmingham, Inst Canc & Genom Sci, Canc Res UK Clin Trials Unit, Birmingham B15 2TT, England

[12] Fdn IRCCS Ist Nazl Tumori, I-20133 Milan, Italy

[13] Univ Hosp Copenhagen, DK-2200 Copenhagen, Denmark

[14] Univ Hosp Bristol & Weston NHS Fdn Trust, Dept Paediat Oncol, Bristol BS1 3NU, England

[15] Univ Padua, Dept Women & Childrens Hlth, I-35122 Padua, Italy

[16] Alices Arc Charity, London EC1V 1AW, England

[17] KickCancer Fdn, B-1000 Brussels, Belgium

[18] Newcastle Univ, Translat & Clin Res Inst, Vivo Biobank, Ctr Canc, Newcastle Upon Tyne NE1 7RU, England

来源：

CANCERS | 2024年 / 16卷 / 05期

关键词：

rhabdomyosarcoma; clinical trial; chemotherapy; radiotherapy; randomisation; novel agents; FaR-RMS; EpSSG; PET RESPONSE CRITERIA; QUALITY-OF-LIFE; PHASE-II; RADIATION-THERAPY; STUDY-IV; NONMETASTATIC RHABDOMYOSARCOMA; RISK RHABDOMYOSARCOMA; INTERNATIONAL SOCIETY; PROGNOSTIC-FACTORS; YOUNG-ADULTS;

D O I：

10.3390/cancers16050998

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) clinical trial is an overarching, multinational study for children and adults with rhabdomyosarcoma (RMS). The trial, developed by the European Soft Tissue Sarcoma Study Group (EpSSG), incorporates multiple different research questions within a multistage design with a focus on (i) novel regimens for poor prognostic subgroups, (ii) optimal duration of maintenance chemotherapy, and (iii) optimal use of radiotherapy for local control and widespread metastatic disease. Additional sub-studies focusing on biological risk stratification, use of imaging modalities, including [F-18]FDG PET-CT and diffusion-weighted MRI imaging (DWI) as prognostic markers, and impact of therapy on quality of life are described. This paper forms part of a Special Issue on rhabdomyosarcoma and outlines the study background, rationale for randomisations and sub-studies, design, and plans for utilisation and dissemination of results.

引用

页数：24

共 50 条

[31] Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: The Prospective NRSTS 2005 Study by the European Pediatric Soft Tissue Sarcoma Study Group (EPSSG)
Ferrari, A.
Van Noesel, M. M.
Brennan, B.
Zanetti, I.
Corradini, N.
Casanova, M.
Berlanga, P.
Merks, J.
Alaggio, R.
Schifflers, S.
Ramirez-Villar, G.
Giraudo, C.
Burrieza, G. Guillen
Safwat, A.
Bisogno, G.
De Salvo, G. L.
Orbach, D.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S55 - S55
[32] Indeterminate Pulmonary Nodules at Diagnosis in Rhabdomyosarcoma: Are They Clinically Significant? A Report From the European Paediatric Soft Tissue Sarcoma Study Group
Vaarwerk, Bas
Bisogno, Gianni
McHugh, Kieran
Brisse, Herve J.
Morosi, Carlo
Corradini, Nadege
Jenney, Meriel
Orbach, Daniel
Chisholm, Julia C.
Ferrari, Andrea
Zanetti, Ilaria
De Salvo, Gian Luca
van Rijn, Rick R.
Merks, Johannes H. M.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (09) : 723 - +
[33] INITIAL SURGERY IN PATIENTS WITH NON METASTATIC RHABDOMYOSARCOMA (RMS): ANALYSIS OF COMPLIANCE TO SURGICAL GUIDELINES OF THE EUROPEAN PAEDIATRIC SARCOMA STUDY GROUP (EPSSG) RMS2005 PROTOCOL
De Corti, Federica
Cecchetto, Giovanni
De Salvo, Gianluca
Rogers, Timothy
Zanetti, Ilaria
Bisogno, Gianni
Martelli, Helene
PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 717 - 717
[34] Prognostic Significance and Tumor Biology of Regional Lymph Node Disease in Patients with Embryonal Rhabdomyosarcoma: Report from The European Soft Tissue Sarcoma Study Group (EPSSG)
Ben Arush, M.
De Salvo, G. L.
Mandeville, H.
Van Scheltinga, S. Terwisscha
Merks, J.
Minard-Colin, V.
Jenney, M.
Gallego, S.
Zanetti, I.
Bisogno, G.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S18 - S18
[35] Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)
Ferrari, A.
De Salvo, G. L.
Brennan, B.
van Noesel, M. M.
De Paoli, A.
Casanova, M.
Francotte, N.
Kelsey, A.
Alaggio, R.
Oberlin, O.
Carli, M.
Ben-Arush, M.
Bergeron, C.
Merks, J. H. M.
Jenney, M.
Stevens, M. C.
Bisogno, G.
Orbach, D.
ANNALS OF ONCOLOGY, 2015, 26 (03) : 567 - 572
[36] Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial
Bisogno, Gianni
Minard-Colin, Veronique
Haduong, Josephine
Zanetti, Ilaria
Ferrari, Andrea
Chisholm, Julia
Heske, Christine M.
Hladun, Raquel
Jenney, Meriel
Merks, Johannes Hendrikus Maria
Venkatramani, Rajkumar
PEDIATRIC BLOOD & CANCER, 2025, 72 (02)
[37] LOCO-Regional Treatment of Para-Testicular Rhabdomyosarcoma (PRMS) A Report from the European Pediatric Soft-Tissue Sarcoma Group (EPSSG)
Rogers, T.
De Corti, F.
Guillen, G.
Guerin, F.
van Scheltinga, S. Terwisscha
Smeulders, N.
Craigie, R.
Jenney, M.
Kelsey, A.
Zanetti, I.
Coppadoro, B.
De Salvo, G. L.
Bisogno, G.
Martelli, H.
PEDIATRIC BLOOD & CANCER, 2019, 66 : S92 - S93
[38] Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Ferrari, Andrea
Trama, Annalisa
De Paoli, Angela
Bergeron, Christophe
Merks, Johannes H. M.
Jenney, Meriel
Orbach, Daniel
Chisholm, Julia C.
Gallego, Soledad
Glosli, Heidi
De Salvo, Gian Luca
Botta, Laura
Gatta, Gemma
Bisogno, Gianni
PEDIATRIC BLOOD & CANCER, 2017, 64 (06)
[39] Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group
Ben-Arush, Myriam
Minard-Colin, Veronique
Scarzello, Giovanni
Fajardo, Raquel D.
Van Scheltinga, Sheila Terwisscha
Bernier, Valerie
Jenney, Meriel
Gallego, Soledad
Zanetti, Ilaria
Cesen, Maja
Merks, Johannes H. M.
Bisogno, Gianni
EUROPEAN JOURNAL OF CANCER, 2022, 172 : 119 - 129
[40] EPITHELIOID HEMANGIOENDOTHELIOMA IN CHILDREN: THE EUROPEAN PEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP (EPSSG) EXPERIENCE
Orbach, Daniel
Van Noesel, Max M.
Brennan, Bernadette
Casanova, Michela
Schifflers, Stefan
Corradini, Nadege
Alaggio, Rita
Burrieza, Gabriela
Schoot, Reineke
Berlanga, Pablo
Zanetti, Ilaria
Hjalgrim, Lisa
Ramirez, Gema
Ferrari, Andrea
PEDIATRIC BLOOD & CANCER, 2022, 69 : S256 - S257

← 1 2 3 4 5 →